The COVID-19 pandemic has caused the biggest decrease in life expectancy since World War II
On Sept. 17, 2021, Oxfordﾒs Leverhulme Centre for Demographic Science reported the COVID-19 pandemic triggered life expectancy losses…
-
-
Zoo Atlanta reported nine western lowland gorillas tested positive for COVID-19
On Sept. 17, 2021, Zoo Atlanta reported that of the 20 gorillas at the Zoo, 18 showed clinical…
-
CDC to invest $2.1 billion to protect patients and healthcare workers from COVID-19 and future infectious diseases
On Sept. 17, 2021, the Centers for Disease Control and Prevention (CDC) announced a $2.1 billion investment to…
-
US Department of Defense awarded $647 million in contracts for over-the-counter COVID-19 test kits
On Sept. 17, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
-
Great cats tested presumptive positive for COVID-19 at the Smithsonian’s National Zoo
On Sept. 17, 2021, the lions and tigers at the Smithsonian’s National Zoo were reported testing presumptive positive…
-
Celsion and Hainan Poly Pharm signed agreement to manufacture Celsionﾒs DNA-based vaccine
On Sept. 16, 2021, Celsion and Hainan Poly Pharm announced an amendment to their existing contract manufacturing agreement…
-
Africa faced 470 million COVID-19 vaccine shortfall in 2021
On Sept. 16, 2021, the WHO reported that the continent faced almost 500 million doses short of the…
-
Moderna announces Health Canada approves its COVID-19 vaccine
On Sept. 16, 2021, Moderna announced Health Canada had approved the New Drug Submission (NDS-CV) for SPIKEVAX (elasomeran…
-
Novavax included in University of Oxford Com-COV3 study comparing mixed COVID-19 vaccine in adolescents
On Sept. 16, 2021, Novavax announced its participation in a newly expanded Phase 2 clinical trial called Comparing…
-
NIH builds large nationwide study population of tens of thousands to support research on long-term effects of COVID-19
On Sept. 15, 2021, the National Institutes of Health (NIH) awarded nearly $470 million to build a national…
-
Biotechnology | COVID-19 | Diagnostics | FDA
InBios received FDA EUA for COVID-19 IgG antibody rapid test
On Sept. 15, 2021, InBios announced that it had received Emergency Use Authorization from the U.S. Food and…
-
Guinea declared end of Marburg virus disease outbreak
On Sept. 15, 2021, Guinea declared the end of the Marburg virus disease outbreak having recorded no new…
-
US Department of Defense awarded $3.2 billion in contract modifications for monoclonal antibodies
On Sept. 15, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
-
Moderna reported clinical data on its COVID-19 vaccine
On Sept. 15, 2021, Moderna announced new analysis suggesting that the COVID-19 vaccine was highly effective against circulating…
-
Oragenics initiated COVID-19 challenge study evaluating multiple formulations of its SARS-CoV-2 vaccine candidate
On Sept. 15, 2021, Oragenics announced the initiation of a study to evaluate the immunogenicity and viral load…
-
Misdirected antibodies linked to severe COVID-19
On Sept. 14, 2021, the NIH announced that an international project called the COVID Human Genetic Effort has…
-
World global health leaders made urgent call to accelerate vaccination globally
On Sept. 14, 2021, the WHO Director General Dr Tedros Adhanom Ghebreyesus and a group of global health…
-
Twist Bioscience committed to deliver synthetic RNA controls to fight Delta plus variants of COVID-19
On Sept. 14, 2021, Twist Bioscience announced that it had started shipping its synthetic RNA reference controls for…
-
Emergent BioSolutions announced manufacturing agreement with Providence Therapeutics for mRNA COVID-19 vaccine candidate
On Sept. 14, 2021, Emergent BioSolutions announced a five-year contract development and manufacturing (CDMO) services agreement spanning Emergentﾒs…
-
Regeneron announced U.S. Government agreement to purchase additional REGEN-COV antibody cocktail
On Sept. 14, 2021, Regeneron announced an agreement with the U.S. Department of Health and Human Services and…
-
City of Hope trial was first to test an investigational COVID-19 vaccine in immunocompromised bone marrow transplant
On Sept. 14, 2021, City of Hope announced that it had begun enrolling patients in a Phase 2…
-
Twist Bioscience collaborates with Adicet Bio to accelerate discovery of Gamma Delta T cell cancer therapeutics
On Sept. 13, 2021, Twist Bioscience announced and Adicet Bio announced a collaboration to accelerate the discovery of…
-
Atlanta Zoo’s western lowland gorillas tested presumptive positive for COVID-19
On Sept. 10, 2021, Zoo Atlanta reported that it had received presumptive positive test results indicating that members…
-
US Department of Defense awarded $35.8 million contract to Mettler-Toledo Rainin to increase domestic production capacity of pipette tips
On Sept. 10, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
-
T2 Biosystems T2SARS-CoV-2 panel proved capable of detecting Mu B.1.621 and Iota B.1.526 variants of SARS-CoV-2 virus
On Sept. 9, 2021, T2 Biosystems announced that its T2SARS-CoV-2 Panel – a molecular diagnostic test that detected…
-
Biotechnology | Genomics | NIH | Therapeutics
NIH provided $185 million for research to advance understanding of how human genome functions
On Sept. 9, 2021, the National Institutes of Health (NIH) announced that it was providing approximately $185 million…
-
Bio-Techne and Carterra initiateed clinical research collaboration for COVID-19 variant analysis
On Sept. 8, 2021, Bio-Techne and Carterra announced a clinical research collaboration studying COVID-19 variants. To assess immune…
-
Resilience to manufacture mRNA for Moderna’s COVID-19 vaccine
On Sept. 8, 2021, National Resilience announced an agreement to manufacture mRNA for the Moderna COVID-19 vaccine. Under…
-
Novavax initiated phase 1/2 clinical trial of combination vaccine for COVID-19 and seasonal influenza
On Sept. 8, 2021, Novavax announced enrollment of the first participants in a Phase 1/2 study to evaluate…
-
AIM ImmunoTech submitted pre-IND application to FDA for phase 2 clinical study of Ampligen for post-COVID-19 cognitive dysfunction
On Sept. 8, 2021, AIM ImmunoTech announced that is had submitted a Pre-Investigational New Drug application (Pre-IND) to…
